Brought to you by 
Integra LifeSciences sells $350mm of convertible notes
19 Jun 2007
Executive Summary
Integra LifeSciences (regenerative biomaterials and implantable devices) sold a total of $350mm of senior convertible notes. Investors purchased $165mm principle amount of 2.75% notes due 2010 that convert at $66.26 a share and $165mm of 2.375% notes due 2012 that convert at $64.96 per share. Integra's stock was averaging $50.49 at the time of the sale.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Integra LifeSciences sells $350mm of convertible notes
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice